Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Polanczyk, M. Lima, B. Horta, J. Biederman, L. Rohde (2007)
The worldwide prevalence of ADHD: a systematic review and metaregression analysis.The American journal of psychiatry, 164 6
T. Clancy, J. Rucklidge, D. Owen (2006)
Road-Crossing Safety in Virtual Reality: A Comparison of Adolescents With and Without ADHDJournal of Clinical Child & Adolescent Psychology, 35
S. Visser, R. Bitsko, M. Danielson, R. Perou, S. Blumberg (2010)
Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.MMWR. Morbidity and mortality weekly report, 59 44
Kenneth Man, E. Chan, D. Coghill, I. Douglas, P. Ip, L. Leung, M. Tsui, W. Wong, I. Wong (2015)
Methylphenidate and the Risk of TraumaPediatrics, 135
R. Barkley, M. Fischer, Lori Smallish, K. Fletcher (2002)
The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder.Journal of abnormal psychology, 111 2
Jihyung Hong, D. Novick, T. Treuer, W. Montgomery, V. Haynes, S. Wu, J. Haro (2013)
Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East AsiaPatient preference and adherence, 7
Brigette Vaughan, C. Kratochvil (2012)
Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder.Child and adolescent psychiatric clinics of North America, 21 4
D. Clemow, C. Bushe (2015)
Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patientsJournal of Psychopharmacology, 29
R. Rowe, B. Maughan, R. Goodman (2004)
Childhood psychiatric disorder and unintentional injury: findings from a national cohort study.Journal of pediatric psychology, 29 2
Michal Gazer-Snitovsky, A. Brand-Gothelf, G. Dubnov-Raz, Abraham Weizman, D. Gothelf (2019)
High Familial Correlation in Methylphenidate Response and Side Effect ProfileJournal of Attention Disorders, 23
J. Setyawan, bullet Moshe, Fridman bullet, P. Hodgkins, J. Quintero, bullet Haim, Erder bullet, V. Harpin (2014)
Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspectiveAttention Deficit and Hyperactivity Disorders, 7
Chia‐Jui Tsai, Charles Lee, S. Liang, Pei-Jung Tsai, V. Chen, M. Gossop (2018)
Risk of ADHD After Multiple Exposures to General Anesthesia: A Nationwide Retrospective Cohort StudyJournal of Attention Disorders, 22
Yuan-Chang Hsu, I-Chia Chien, H. Tan, Ching-Heng Lin, Shu-Wen Cheng, Yiing-Jenq Chou, P. Chou (2013)
Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in TaiwanSocial Psychiatry and Psychiatric Epidemiology, 48
J. Cairney (2014)
Deficits in attention, motor control, and perception and increased risk of injury in childrenDevelopmental Medicine & Child Neurology, 56
Z. Chang, P. Lichtenstein, B. D’Onofrio, A. Sjölander, H. Larsson (2014)
Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study.JAMA psychiatry, 71 3
T. Wiguna, Anthony Guerrero, S. Wibisono, S. Sastroasmoro (2012)
Effect of 12-Week Administration of 20-mg Long-Acting Methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr Ratios in the Prefrontal Cortices of School-Age Children in Indonesia: A Study Using 1H Magnetic Resonance Spectroscopy (MRS)Clinical Neuropharmacology, 35
Chuan-Yu Chen, H. Yeh, Kuang-Hung Chen, I-Shou Chang, E. Wu, Keh‐ming Lin (2011)
Differential effects of predictors on methylphenidate initiation and discontinuation among young people with newly diagnosed attention-deficit/hyperactivity disorder.Journal of child and adolescent psychopharmacology, 21 3
K. Gajria, M. Lu, V. Sikirica, P. Greven, Y. Zhong, P. Qin, Jipan Xie (2014)
Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature reviewNeuropsychiatric Disease and Treatment, 10
Sudha Raman, S. Marshall, K. Haynes, B. Gaynes, A. Naftel, T. Stürmer (2012)
Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study designInjury Prevention, 19
SN Visser, RH Bitsko, ML Danielson, R Perou, SJ Blumberg (2010)
Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children—United States, 2003 and 2007MMWR Morb Mortal Wkly Rep, 59
K. Marel, V. Bouet, G. Meerhoff, T. Freret, M. Boulouard, F. Dauphin, A. Klomp, P. Lucassen, J. Homberg, R. Dijkhuizen, L. Reneman (2015)
Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesisNeuroscience, 309
S. Dalsgaard, J. Leckman, P. Mortensen, H. Nielsen, Marianne Simonsen (2015)
Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study.The lancet. Psychiatry, 2 8
P. Aduen, Michael Kofler, D. Cox, Dustin Sarver, E. Lunsford (2015)
Motor vehicle driving in high incidence psychiatric disability: comparison of drivers with ADHD, depression, and no known psychopathology.Journal of psychiatric research, 64
C. Ertan, Ö. Özcan, M. Pepele (2012)
Paediatric trauma patients and attention deficit hyperactivity disorder: correlation and significanceEmergency Medicine Journal, 29
R. Mikolajczyk, J. Horn, N. Schmedt, I. Langner, C. Lindemann, E. Garbe (2015)
Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.JAMA pediatrics, 169 4
Ching-Lan Cheng, Cheng-han Lee, Po-sheng Chen, Yi-Heng Li, Swu-Jane Lin, Y. Yang (2014)
Validation of Acute Myocardial Infarction Cases in the National Health Insurance Research Database in TaiwanJournal of Epidemiology, 24
R. Barkley, M. Fischer, Lori Smallish, K. Fletcher (2006)
Young adult outcome of hyperactive children: adaptive functioning in major life activities.Journal of the American Academy of Child and Adolescent Psychiatry, 45 2
Min-Jing Lee, Kang-chung Yang, Y. Shyu, Shinsheng Yuan, chun-Ju Yang, Sheng-Yu Lee, Tung-liang lee, Liang-Jen Wang (2016)
Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan.Journal of affective disorders, 189
R. Parslow, K. Morris, R. Tasker, R. Forsyth, C. Hawley (2005)
Epidemiology of traumatic brain injury in children receiving intensive care in the UKArchives of Disease in Childhood, 90
J. Fine, R. Gray (1999)
A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 94
(2011)
Nonfatal traumatic brain injuries related to sports and recreation activities among persons aged ≤19 years—United States, 2001–2009MMWR Morb Mortal Wkly Rep, 60
P. Lichtenstein, L. Halldner, J. Zetterqvist, A. Sjölander, E. Serlachius, S. Fazel, Niklas Långström, H. Larsson (2012)
Medication for attention deficit-hyperactivity disorder and criminality.The New England journal of medicine, 367 21
V. Bali, P. Kamble, R. Aparasu (2015)
Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder.Journal of managed care & specialty pharmacy, 21 6
M. Fredriksen, A. Dahl, E. Martinsen, O. Klungsøyr, J. Haavik, D. Peleikis (2014)
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): An open-label prospective study of time in treatment, dose, side-effects and comorbidityEuropean Neuropsychopharmacology, 24
J. Gilchrist, K. Thomas, Likang Xu, L. Mcguire, V. Coronado (2011)
Nonfatal traumatic brain injuries related to sports and recreation activities among persons aged ≤19 years--United States, 2001-2009.MMWR. Morbidity and mortality weekly report, 60 39
L. Schweren, P. Zeeuw, S. Durston (2013)
MR imaging of the effects of methylphenidate on brain structure and function in Attention-Deficit/Hyperactivity DisorderEuropean Neuropsychopharmacology, 23
Y. Tai, S. Gau, C. Gau (2013)
Injury-proneness of youth with attention-deficit hyperactivity disorder: a national clinical data analysis in Taiwan.Research in developmental disabilities, 34 3
Howard Aj, Dunkin Kt, Jm Musser, Palmer Epidemiology, Booy R, Taylor Sa, Dobson Srm, I. D., Tudor-Williams G, Frankland J, May Rt, Macfarlane Ja, Booy Moxon, Er, M. Slack, Efficacy, C. Yeoh, H. Davies (1993)
Clinical coding: completeness and accuracy when doctors take it on.British Medical Journal, 306
F. Winston, C. McDonald, D. McGehee (2013)
Are we doing enough to prevent the perfect storm?: novice drivers, ADHD, and distracted driving.JAMA pediatrics, 167 10
J. Swanson (2003)
Role of executive function in ADHD.The Journal of clinical psychiatry, 64 Suppl 14
A. Amiri, Gholamreza Parizi, M. Kousha, F. Saadat, M. Modabbernia, K. Najafi, Z. Roushan (2013)
Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit–hyperactivity disorder (ADHD)Progress in Neuro-Psychopharmacology and Biological Psychiatry, 47
Preventive effect of stimulants on the risk of brain injuries had been reported. The aim of this study is to determine the extent to which methylphenidate (MPH) prescription moderates the risk of traumatic brain injuries (TBI) in individuals with attention-deficit/hyperactivity disorder (ADHD). Individuals with a recent diagnosis of ADHD between January 1997 and December 2013 (n = 163,618) were identified from Taiwan’s National Health Insurance Research Database. A total of 124,438 adolescents and children with ADHD and without prior TBI diagnoses were included and evaluated for subsequent TBI. Methylphenidate prescription duration was subgrouped by the annual average cumulative defined daily dose (DDD): 0, >0 to ≤28, > 28 to ≤84, and >84. We identified 11,463 diagnoses of TBI among 124,438 adolescents and children with ADHD. A Cox regression model was used to investigate whether MPH prescription influenced the risk for TBI after adjusting for sex, age, level of urbanization, seizure, autism and sedative–anxiolytics use. A reduced TBI incidence was observed with MPH prescription DDDs > 84. The protective effect of MPH against TBI persisted after adjusting for confounding factors [hazard ratio (HR) = 0.49; 95% confidence interval (CI): 0.47–0.51]. There was also statistically significant difference in risk for TBI in subjects receiving > 0 to ≤28 or >28 to ≤84 DDDs of MPH treatment (HR = 0.88, 95% CI = 0.83–0.92; HR = 0.76, 95% CI = 0.72–0.80, respectively) when compared with subjects not receiving treatment with MPH. Treatment with MPH for greater than 84 DDDs reduced the risk for TBI among children with ADHD.
European Child & Adolescent Psychiatry – Springer Journals
Published: Aug 30, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.